Celldex Therapeutics
CLDX
#4691
Rank
ยฃ1.47 B
Marketcap
ยฃ22.20
Share price
6.44%
Change (1 day)
6.10%
Change (1 year)

Celldex Therapeutics (CLDX) - Net assets

Net assets on the balance sheet as of September 2025 : ยฃ0.44 Billion

According to Celldex Therapeutics's latest financial reports the company has ยฃ0.44 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Celldex Therapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$ยฃ0.59 B76.71%
2023-12-31$ยฃ0.33 B24.94%
2022-12-31$ยฃ0.26 B-13.23%
2021-12-31$ยฃ0.31 B102.33%
2020-12-31$ยฃ0.15 B114.2%
2019-12-31$ยฃ71.7 M-26.63%
2018-12-31$ยฃ97.73 M-44.12%
2017-12-31$ยฃ0.17 B-18.7%
2016-12-31$ยฃ0.21 B9.89%
2015-12-31$ยฃ0.19 B44%
2014-12-31$ยฃ0.13 B-29.88%
2013-12-31$ยฃ0.19 B227.18%
2012-12-31$ยฃ59.25 M34.02%
2011-12-31$ยฃ44.21 M-9.3%
2010-12-31$ยฃ48.74 M6.94%
2009-12-31$ยฃ45.58 M268.43%
2008-12-31$ยฃ12.37 M-2271.61%
2007-12-31$-ยฃ0.57 Million-151.64%
2006-12-31$ยฃ1.1 M-90.89%
2005-12-31$ยฃ12.11 M-39.45%
2004-12-31$ยฃ20 M28.18%
2003-12-31$ยฃ15.6 M-20.16%
2002-12-31$ยฃ19.54 M-37.39%
2001-12-31$ยฃ31.22 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Seagen
SGEN
ยฃ1.91 B 326.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
-ยฃ0.22 Billion-146.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.43 B-2.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ7.21 B 1,507.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ69.83 B 15,458.45%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ15.88 B 3,438.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
ยฃ2.09 M-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA